Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Cox

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Health Technology Assessment (Winchester, England)|November 15, 2025
Clinical and cost-effectiveness of a standardised diagnostic assessment for children and adolescents with emotional difficulties: the STADIA multi-centre RCTKapil Sayal, Laura Wyatt, Louise Thomson, et al.
Nature|July 5, 2002
Sequence and analysis of chromosome 2 of Dictyostelium discoideumGernot Glöckner, Ludwig Eichinger, Karol Szafranski, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
The Cost-Effectiveness of the SMART Work & Life Intervention for Reducing Sitting TimeEdward Cox, Simon Walker, Charlotte L Edwardson, et al.
Health Technology Assessment (Winchester, England)|November 4, 2023
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysisNadeem Qureshi, Bethan Woods, Rita Neves de Faria, et al.
Public Health Research (Southampton, England)|October 3, 2023
A multicomponent intervention to reduce daily sitting time in office workers: the SMART Work & Life three-arm cluster RCTCharlotte L Edwardson, Benjamin D Maylor, Stuart Jh Biddle, et al.
BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Journal of the Pediatric Infectious Diseases Society|October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Health Technology Assessment (Winchester, England)|November 15, 2025
Clinical and cost-effectiveness of a standardised diagnostic assessment for children and adolescents with emotional difficulties: the STADIA multi-centre RCTKapil Sayal, Laura Wyatt, Louise Thomson, et al.
Nature|July 5, 2002
Sequence and analysis of chromosome 2 of Dictyostelium discoideumGernot Glöckner, Ludwig Eichinger, Karol Szafranski, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
The Cost-Effectiveness of the SMART Work & Life Intervention for Reducing Sitting TimeEdward Cox, Simon Walker, Charlotte L Edwardson, et al.
Health Technology Assessment (Winchester, England)|November 4, 2023
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysisNadeem Qureshi, Bethan Woods, Rita Neves de Faria, et al.
Public Health Research (Southampton, England)|October 3, 2023
A multicomponent intervention to reduce daily sitting time in office workers: the SMART Work & Life three-arm cluster RCTCharlotte L Edwardson, Benjamin D Maylor, Stuart Jh Biddle, et al.
BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Journal of the Pediatric Infectious Diseases Society|October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 4